Literature DB >> 3356109

Effects of pH and osmolarity on aerosol-induced cough in normal volunteers.

R H Lowry1, A M Wood, T W Higenbottam.   

Abstract

1. The chemosensitivity of cough receptors stimulated by inhalation of aqueous aerosols was evaluated in 21 normal volunteers in three experiments. 2. The pH of isotonic saline was altered using small amounts of phosphate or glycine buffers to produce solutions with a pH range of 2.6-10.0. These solutions were nebulized ultrasonically and breathed for 1 min periods by seven subjects in random order and on separate days. Cough frequency during each 1 min inhalation was recorded. Only the two solutions of extreme pH (2.6 and 10.0) caused cough. 3. The effect of altering the osmolarity of the inhaled aerosol on cough was assessed using D-glucose over a range of 77-1232 mosmol/l. Saline solutions over the same range of osmolarity were also tested. The pH of D-glucose was raised to match that of saline by adding small amounts of sodium hydroxide. All solutions were nebulized and inhaled by seven subjects as described above for 1 min periods during which cough frequency was recorded. Forced expired volume in 1 s was recorded after each inhalation and did not alter in any subject by more than 10%. Subjects coughed when inhaling all the D-glucose solutions over the whole range of osmolarity. Cough occurred with saline solutions only at low chloride concentration and at the highest concentration. 4. In order to clarify whether the response to hypertonic saline was due to the high ionic content of the solutions or to its hypertonicity, two other solutions were tested. These were an isotonic and a hypertonic mixture of D-glucose and saline, containing 'normal' (150 mmol/l) ionic content.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3356109     DOI: 10.1042/cs0740373

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  19 in total

Review 1.  Cough challenge in the assessment of cough reflex.

Authors:  A H Morice; J A Kastelik; R Thompson
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

Review 2.  Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia.

Authors:  G Christopher Wood; Joseph M Swanson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Osmolality and pH of anti-asthmatic drug solutions.

Authors:  K N Desager; H P Van Bever; W J Stevens
Journal:  Agents Actions       Date:  1990-11

4.  Development of a High-Flow Nasal Cannula and Pharmaceutical Aerosol Combination Device.

Authors:  Benjamin M Spence; Worth Longest; Xiangyin Wei; Sneha Dhapare; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-03-11       Impact factor: 2.849

5.  Acid-sensing by airway afferent nerves.

Authors:  Lu-Yuan Lee; Qihai Gu; Fadi Xu; Ju-Lun Hong
Journal:  Pulm Pharmacol Ther       Date:  2013-03-21       Impact factor: 3.410

Review 6.  Cough as an adverse effect on inhalation pharmaceutical products.

Authors:  Rachel Yoon Kyung Chang; Philip Chi Lip Kwok; Sussan Ghassabian; John D Brannan; Heikki O Koskela; Hak-Kim Chan
Journal:  Br J Pharmacol       Date:  2020-08-07       Impact factor: 8.739

7.  The effect of anticholinergic bronchodilator therapy on cough during upper respiratory tract infections.

Authors:  R Lowry; A Wood; T Higenbottam
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

8.  Mechanisms of acid-induced activation of airway afferent nerve fibres in guinea-pig.

Authors:  Marian Kollarik; Bradley J Undem
Journal:  J Physiol       Date:  2002-09-01       Impact factor: 5.182

Review 9.  Central regulation of the cough reflex: therapeutic implications.

Authors:  Brendan J Canning
Journal:  Pulm Pharmacol Ther       Date:  2009-01-20       Impact factor: 3.410

10.  A Proof of Concept Study to Detect Urease Producing Bacteria in Lungs Using Aerosolized 13C-Urea.

Authors:  Hengameh H Raissy; Graham Timmins; Lea Davies; Theresa Heynekamp; Michelle Harkins; Zachary D Sharp; H William Kelly
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2016-06-01       Impact factor: 1.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.